Skip to main content
Clinical Trials/NCT03324971
NCT03324971
Completed
Not Applicable

Effect of Reducing Medication Regimen Complexity on Glycemic Control in Patients With Diabetes.

Kasr El Aini Hospital1 site in 1 country78 target enrollmentJune 2, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diabetes Mellitus
Sponsor
Kasr El Aini Hospital
Enrollment
78
Locations
1
Primary Endpoint
Change in Hemoglobin A1c
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

Polypharmacy is an alarming health issue that is defined as prescription of multiple medications, of which some are redundant or unnecessary. Due to comorbidities, diabetic patients are often prescribed multiple medications. Over prescribing occurs either due to, prescribing medications that are not indicated, continuation of certain medications beyond the time of indication, or prescribing more than one medication with the same effect. Improving glycaemic control is the cornerstone for the prevention and treatment of the diabetic complications.

Detailed Description

Hypothesis In addition to the side effects and cost of the unnecessary medications, the investigators hypothesis is that poly-pharmacy will adversely affect patients' compliance with the necessary medications.The investigators propose that elimination of unnecessary medications might improve patients' compliance and consequently improve glycemic control diabetic patients.

Registry
clinicaltrials.gov
Start Date
June 2, 2017
End Date
December 7, 2017
Last Updated
7 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Kasr El Aini Hospital
Responsible Party
Principal Investigator
Principal Investigator

Tarek Samy Abdelziz

Senior lecturer

Kasr El Aini Hospital

Eligibility Criteria

Inclusion Criteria

  • All diabetic patients who are eligible by fulfilling all of the following criteria:
  • HGBA1c ≥7 mg/dl.
  • Poly-pharmacy: defined as the use of five or more medications.
  • Non- compliance: patients were surveyed with both direct and indirect methods to identify non adherence.

Exclusion Criteria

  • Exclusion after recruitment Any patient whose diabetic medications regimen changed after recruitment due to hospitalisation, illness, stress or patients preference, will be excluded.

Outcomes

Primary Outcomes

Change in Hemoglobin A1c

Time Frame: 3 months

measurement of hemoglobin A1c to determine glycemic control.

Study Sites (1)

Loading locations...

Similar Trials